Skip to content
10-K

Annual Report

BIO-TECHNE Corp TECH

0001558370-24-012430

← back to feed
Filed
Aug 22, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Aug 16, 2024 158.6M sh
Stockholders Equity FY 2024 · Jun 30, 2024 $2.07B
Stockholders Equity FY 2024 · Jun 30, 2023 $1.97B
Short Term Investments FY 2024 · Jun 30, 2023 $23.74M
Cash And Equivalents FY 2024 · Jun 30, 2023 $180.57M
Current Liabilities FY 2024 · Jun 30, 2023 $128.51M
Current Assets FY 2024 · Jun 30, 2023 $621.48M
Total Assets FY 2024 · Jun 30, 2023 $2.64B
Shares Diluted restated FY 2024 · Jun 30, 2022 164.11M sh
Stock Repurchased FY 2024 · Jun 30, 2022 $160.95M
Dividends Paid FY 2024 · Jun 30, 2022 $50.19M
Capex FY 2024 · Jun 30, 2022 $44.91M
Operating Cash Flow FY 2024 · Jun 30, 2022 $325.27M
Eps Diluted restated FY 2024 · Jun 30, 2022 $1.66
Eps Basic restated FY 2024 · Jun 30, 2022 $1.73
Sga Expense FY 2024 · Jun 30, 2022 $372.77M
Net Income FY 2024 · Jun 30, 2022 $272.05M
Operating Income FY 2024 · Jun 30, 2022 $296.59M
Gross Profit FY 2024 · Jun 30, 2022 $756.5M
Cost Of Revenue FY 2024 · Jun 30, 2022 $349.1M
Revenue FY 2024 · Jun 30, 2022 $1.11B